KOSPI · Healthcare · ₩970B
₩16,590-0.60%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 20.7% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“해외 신약 확장이 대웅의 다음 성장을 이끌고 있어요.”
In the company's words · 2026 2분기 filing